// App-Quantinova.ai

: Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy

Researchers

Presenter

  • Miriana d'Alessandro

Principal Investigators

  • Laura Bergantini

  • Paolo Cameli

  • Maria Pieroni

  • Rosa Metella Refini

  • Piersante Sestini

  • Elena Bargagli

Medical Centers

  • Respiratory Diseases and Lung Transplantation Unit, Department of Medical, Surgical and Neuro Sciences, University of Siena, Siena, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Idiopathic pulmonary fibrosis

  • Extrinsic allergic alveolitis

  • Pulmonary fibrosis

  • Lung Cancer

  • Pulmonary alveolar proteinosis

  • Solid malignancies

Biomarkers

  • Kerbs von Lungren 6 antigen

Drug/Treatment

  • Nintedanib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A